CLINICAL_TRIALS
trial_result
· 2024-03-20
Clinical Trial Update: S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery [Phase 3]
Summary
A Phase 3 trial (S0931) evaluating everolimus as adjuvant therapy after kidney cancer surgery has completed, with results posted. The study investigates whether…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: SWOG Cancer Research Network | Conditions: Kidney Cancer | Phase 3 | Status: COMPLETED | Results posted: 2024-03-20